5.361 Expression and Purification of Enzyme Mutants (New)


Class Info

Students use biochemical techniques for protein expression and DNA manipulation of Bcr-Abl kinase, which is inhibited by the blockbuster drug Gleevec in the treatment of chronic myelogenous leukemia. Uses various standard bioanalytical and biochemical methods in lab to characterize and produce this protein.

This class has 5.07, 7.05, 5.352, 5.310, and 5.362 as prerequisites.

5.361 will be offered this semester (Spring 2018). It is instructed by .

This class counts for a total of 3 credits.

You can find more information at the Module Descriptions site.

MIT 5.361 Expression and Purification of Enzyme Mutants (New) Related Textbooks
MIT 5.361 Expression and Purification of Enzyme Mutants (New) On The Web

© Copyright 2015